<?xml version='1.0' encoding='UTF-8'?><batch xmlns="http://www.quertle.com/schema/UFT" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.quertle.com/schema/UFT uft.xsd" schemaVersion="1.1"><doc><news-meta><stream>Fierce Pharma Vaccines</stream></news-meta><doc-meta><doc-ids><doc-id type="pii">pharma_20180917_0</doc-id></doc-ids><date-published><year>2018</year><month>09</month><day>17</day></date-published><authors><author><last-name>Sagonowsky</last-name><first-name>Eric</first-name></author></authors><title>Pfizer 'all in' on advancing next-generation pneumococcal vaccine candidate: CFO </title></doc-meta><content><body><section><text>The race is on for a next-generation pneumococcal vaccine. Merck has already pushed its 15-valent candidate into phase 3, and on Thursday, Pfizer CFO Frank D’Amelio said his company is “all in” on reaching the market as soon as possible with its candidate. 
</text></section></body></content><extra><ext-links><ext-link type="url" view-type="html">https://www.fiercepharma.com/vaccines/pfizer-all-advancing-next-gen-pneumococcal-vaccine-candidate-cfo</ext-link></ext-links></extra></doc><doc><news-meta><stream>Fierce Pharma Vaccines</stream></news-meta><doc-meta><doc-ids><doc-id type="pii">pharma_20180725_0</doc-id></doc-ids><date-published><year>2018</year><month>07</month><day>25</day></date-published><authors><author><last-name>Shakya</last-name><first-name>Ashesh</first-name></author><author><last-name>Shakya</last-name><first-name>Niraj</first-name></author></authors><title>News of Note—GlaxoSmithKline, Ebola and SK Bioscience </title></doc-meta><content><body><section><text>Here is some other vaccine news of note for the week.
> GlaxoSmithKline has reported £1.25 billion ($1.65 billion) in second-quarter vaccine sales, a 16% increase at constant currencies. Reuters story
> The World Health Organization has declared an end to the Ebola outbreak in the Democratic Republic of Congo. Release
Free Daily NewsletterLike this story? Subscribe to FiercePharma!Biopharma is a fast-growing world where big ideas come along daily. Our subscribers rely on FiercePharma as their must-read source for the latest news, analysis and data on drugs and the companies that make them. Sign up today to get pharma news and updates delivered to your inbox and read on the go.SUBSCRIBE NOW> South Korea's SK Bioscience is spending $89 million on a plant to increase vaccine capacity. Pulse story
</text></section></body></content><extra><ext-links><ext-link type="url" view-type="html">https://www.fiercepharma.com/vaccines/news-note-glaxosmithkline-ebola-and-sk-bioscience</ext-link></ext-links></extra></doc><doc><news-meta><stream>Fierce Pharma Vaccines</stream></news-meta><doc-meta><doc-ids><doc-id type="pii">pharma_20181106_0</doc-id></doc-ids><date-published><year>2018</year><month>11</month><day>06</day></date-published><authors><author><last-name>Shrestha</last-name><first-name>Narendra</first-name></author></authors><title>News of Note—Pfizer results, GSK shortage and more </title></doc-meta><content><body><section><text>Here is some other vaccine news of note for the week:
> Pfizer's vaccine sales in the third quarter grew 12% to $1.85 billion. Prevnar 13 sales in the U.S. were up 12% due to the timing of government purchases. Release (PDF)
> Pharmacists in Canada are reporting a shortage of GlaxoSmithKline's hep A and B vaccine for travelers Twinrix. CBC article
Free Daily NewsletterLike this story? Subscribe to FiercePharma!Biopharma is a fast-growing world where big ideas come along daily. Our subscribers rely on FiercePharma as their must-read source for the latest news, analysis and data on drugs and the companies that make them. Sign up today to get pharma news and updates delivered to your inbox and read on the go.SUBSCRIBE NOW> A subsidiary of South Korea's GC Pharma received approval to start phase 1 testing of a shingles vaccine. Release
> Enesi Pharma entered an R&amp;D deal to work on vaccines against Chikungunya, Zika and peanut allergy. Release
</text></section></body></content><extra><ext-links><ext-link type="url" view-type="html">https://www.fiercepharma.com/vaccines/news-note-pfizer-results-gsk-shortage-and-more</ext-link></ext-links></extra></doc></batch>